DNLI
Price
$13.27
Change
+$0.57 (+4.49%)
Updated
Apr 14 closing price
Capitalization
1.93B
28 days until earnings call
NUVL
Price
$70.00
Change
+$3.71 (+5.60%)
Updated
Apr 14 closing price
Capitalization
5.01B
23 days until earnings call
Ad is loading...

DNLI vs NUVL

Header iconDNLI vs NUVL Comparison
Open Charts DNLI vs NUVLBanner chart's image
Denali Therapeutics
Price$13.27
Change+$0.57 (+4.49%)
Volume$1.8M
Capitalization1.93B
Nuvalent
Price$70.00
Change+$3.71 (+5.60%)
Volume$486.81K
Capitalization5.01B
DNLI vs NUVL Comparison Chart
Loading...
DNLI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NUVL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DNLI vs. NUVL commentary
Apr 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DNLI is a Hold and NUVL is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 15, 2025
Stock price -- (DNLI: $12.70 vs. NUVL: $70.00)
Brand notoriety: DNLI and NUVL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DNLI: 119% vs. NUVL: 83%
Market capitalization -- DNLI: $1.93B vs. NUVL: $5.01B
DNLI [@Biotechnology] is valued at $1.93B. NUVL’s [@Biotechnology] market capitalization is $5.01B. The market cap for tickers in the [@Biotechnology] industry ranges from $281.29B to $0. The average market capitalization across the [@Biotechnology] industry is $1.99B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DNLI’s FA Score shows that 0 FA rating(s) are green whileNUVL’s FA Score has 0 green FA rating(s).

  • DNLI’s FA Score: 0 green, 5 red.
  • NUVL’s FA Score: 0 green, 5 red.
According to our system of comparison, DNLI is a better buy in the long-term than NUVL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DNLI’s TA Score shows that 5 TA indicator(s) are bullish while NUVL’s TA Score has 4 bullish TA indicator(s).

  • DNLI’s TA Score: 5 bullish, 3 bearish.
  • NUVL’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, DNLI is a better buy in the short-term than NUVL.

Price Growth

DNLI (@Biotechnology) experienced а +7.81% price change this week, while NUVL (@Biotechnology) price change was +8.23% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.28%. For the same industry, the average monthly price growth was -13.99%, and the average quarterly price growth was -22.43%.

Reported Earning Dates

DNLI is expected to report earnings on Jul 31, 2025.

NUVL is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+4.28% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NUVL($5.01B) has a higher market cap than DNLI($1.93B). NUVL YTD gains are higher at: -10.577 vs. DNLI (-34.887). NUVL has higher annual earnings (EBITDA): -280.37M vs. DNLI (-492.89M). NUVL has more cash in the bank: 1.12B vs. DNLI (832M). DNLI (0) and NUVL (0) have equivalent revenues.
DNLINUVLDNLI / NUVL
Capitalization1.93B5.01B38%
EBITDA-492.89M-280.37M176%
Gain YTD-34.887-10.577330%
P/E RatioN/AN/A-
Revenue00-
Total Cash832M1.12B74%
Total Debt48.7MN/A-
FUNDAMENTALS RATINGS
DNLI: Fundamental Ratings
DNLI
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
38
PRICE GROWTH RATING
1..100
90
P/E GROWTH RATING
1..100
97
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DNLINUVL
RSI
ODDS (%)
Bullish Trend 4 days ago
88%
Bullish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 4 days ago
88%
Momentum
ODDS (%)
Bearish Trend 4 days ago
87%
Bearish Trend 4 days ago
80%
MACD
ODDS (%)
Bullish Trend 4 days ago
84%
Bearish Trend 4 days ago
81%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
79%
Bullish Trend 4 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
85%
Bearish Trend 4 days ago
82%
Advances
ODDS (%)
Bullish Trend 18 days ago
79%
Bullish Trend 25 days ago
82%
Declines
ODDS (%)
Bearish Trend 7 days ago
79%
Bearish Trend 7 days ago
79%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
75%
Bullish Trend 4 days ago
88%
Aroon
ODDS (%)
Bearish Trend 4 days ago
83%
Bearish Trend 4 days ago
90%
View a ticker or compare two or three
Ad is loading...
DNLI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NUVL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
NUV8.610.13
+1.53%
Nuveen Municipal Value Fund
BSMU21.200.23
+1.12%
Invesco BulletShares 2030 Muncpl Bd ETF
DFP19.010.14
+0.74%
FLAHERTY & CRUMRINE DYNAMIC PREFERRED AND Income FUND
XDAT21.980.10
+0.46%
Franklin Exponential Data ETF
OVLH33.31-0.03
-0.09%
Overlay Shares Hedged Lrg Cp Eq ETF

DNLI and

Correlation & Price change

A.I.dvisor indicates that over the last year, DNLI has been loosely correlated with RCKT. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if DNLI jumps, then RCKT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DNLI
1D Price
Change %
DNLI100%
+4.49%
RCKT - DNLI
60%
Loosely correlated
+12.14%
BEAM - DNLI
58%
Loosely correlated
+9.89%
NTLA - DNLI
56%
Loosely correlated
+1.21%
CRSP - DNLI
54%
Loosely correlated
-1.25%
RGNX - DNLI
54%
Loosely correlated
+7.47%
More

NUVL and

Correlation & Price change

A.I.dvisor indicates that over the last year, NUVL has been loosely correlated with ABCZF. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if NUVL jumps, then ABCZF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NUVL
1D Price
Change %
NUVL100%
+5.60%
ABCZF - NUVL
51%
Loosely correlated
N/A
KYMR - NUVL
47%
Loosely correlated
+5.43%
ROIV - NUVL
46%
Loosely correlated
+3.35%
CRNX - NUVL
44%
Loosely correlated
+2.30%
IDYA - NUVL
44%
Loosely correlated
+2.15%
More